Trump Announces Medicaid Drug Price Cuts Tied to Global Rates
President Trump says all states have joined a plan to align Medicaid drug prices with those paid by other wealthy nations.
President Trump announced that Medicaid will receive lower prices on certain prescription drugs, framing the move as a significant victory for the federal-state health insurance program that covers tens of millions of low-income Americans. The president said every state had opted into the initiative, signaling broad participation in the effort.
The policy centers on aligning what Medicaid pays for select medicines with the prices negotiated by other wealthy countries, a model sometimes called international reference pricing. Proponents argue the approach could generate substantial savings for both state and federal budgets, given that peer nations routinely pay far less than the United States for the same drugs.
Read more IRS Halts Tax Gap Reporting as Workforce Shrinks Under Trump →
The announcement comes with the midterm elections on the horizon, and the timing underscores the political salience of prescription drug costs as a campaign issue. Lowering drug prices has polled consistently well across party lines, giving the administration a potential messaging advantage heading into a competitive election cycle.
It remains unclear which specific drug categories would be covered under the new pricing structure or how quickly changes would take effect. The mechanics of implementing international reference pricing within Medicaid's complex reimbursement framework are likely to require negotiations with pharmaceutical manufacturers and coordination across state agencies.
Continue reading at NYT > Business
